Home > Journals > The Journal of Cardiovascular Surgery > Past Issues > The Journal of Cardiovascular Surgery 2018 June;59(3) > The Journal of Cardiovascular Surgery 2018 June;59(3):428-37

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Permissions
Cite this article as

 

ORIGINAL ARTICLE  CARDIAC SECTION 

The Journal of Cardiovascular Surgery 2018 June;59(3):428-37

DOI: 10.23736/S0021-9509.17.10188-6

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Initial clinical and hemodynamic results of a regional pulmonary thromboendarterectomy program

Farhan RAZA 1, Anjali VAIDYA 1, Anne-Sophie LACHARITE-ROBERGE 2, Vladimir LAKHTER 1, Hayan AL-MALULI 1, Irfan AHSAN 3, Pamela BOODRAM 4, Chandra DASS 5, Frances ROGERS 1, Martin G. KEANE 1, Sheila WEAVER 6, Riyaz BASHIR 1, Yoshiya TOYODA 7, Paul FORFIA 1

1 Heart and Vascular Institute, Temple University Hospital, Philadelphia, PA, USA; 2 Department of Medicine, Temple University Hospital, Philadelphia, PA, USA; 3 Department of Medicine, Abington Memorial Hospital, Philadelphia, PA, USA; 4 Temple University School of Medicine, Philadelphia, PA, USA; 5 Department of Radiology, Temple University Hospital, Philadelphia, PA, USA; 6 Temple Lung Center, Temple University Hospital, Philadelphia, PA, USA; 7 Department of Cardiovascular Surgery, Temple University Hospital, Philadelphia, PA, USA


PDF


BACKGROUND: Pulmonary thromboendarterectomy (PTE) is the treatment of choice for eligible patients with chronic thromboembolic pulmonary hypertension (CTEPH). However, access to CTEPH and PTE care is limited. There is a paucity of published data on PTE efficacy and outcomes from alternative, regional centers of excellence in CTEPH and PTE care in the USA, outside a single national and international referral center.
METHODS: We performed a retrospective review of patients undergoing PTE at our institution from June 2013 to December 2016 (42 months), and collected clinical, echocardiographic and hemodynamic data on our patients pre- and post-PTE (N.=71).
RESULTS: Patients age ranged between 20-83 years (mean±SD: 56±16), with 54% of patients female and 61% Caucasians. The predominant symptom was shortness of breath with a median duration of symptoms of 17 months. Following PTE, clinical improvements included a reduction in NYHA class from 3.1±1.1 to 2.2±1.2. There were major improvements in hemodynamics and echocardiographic parameters pre- versus post-PTE: mean pulmonary artery pressure (mmHg) 45±11 to 24±8, cardiac index (L/min/m2) 2.1±0.5 to 2.8±0.5, pulmonary vascular resistance (mmHg/L/min) 8.9±4.5 to 2.8±1.8, ratio of right ventricle (RV): left ventricle (LV) 1.2±0.3 to 0.9±0.2, RV fractional area change (%) 23±14 to 44±13, reduction in the incidence of RV outflow tract Doppler notching and improved pulmonary artery acceleration time (96% to 30%, and 74±19 to 111±21). In-hospital mortality was 4.2% (3 patients).
CONCLUSIONS: Herein, we report for the first time, the improvements in patient functionality, hemodynamics, right heart function and outcomes at a major regional PTE program.


KEY WORDS: Hypertension, pulmonary - Endarterectomy - Heart ventricles

top of page